Search

everythinglearnresearchcommunity

for

Search:↓

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Finasteride may help reduce inappropriate sexual behaviors in dementia patients with prostate issues.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Finasteride may reduce depression and anxiety in female rats and improve brain connectivity.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.

Finasteride for female hair loss has low side effects, more research needed.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Finasteride may affect brain chemistry and behavior, offering potential for treating certain mental health conditions.

Bicalutamide may help treat female pattern hair loss.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Finasteride is most linked to drug-induced erectile dysfunction.

Public interest in finasteride's sexual side effects has significantly increased, highlighting the need for better patient discussions.

Taking finasteride daily can effectively and safely increase hair density and thickness for women with hair loss.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Finasteride, dutasteride, and silodosin have the highest risk for causing sexual dysfunction.